Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Petersen

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|December 18, 2012
Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulinF Ostronoff, F Milano, T Gooley, et al.
Bone Marrow Transplantation|August 1, 1993
Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemiaM C Benyunes, C Massumoto, A York, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 11, 2015
The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantationC D Ford, B K Lopansri, M A Gazdik, et al.
Bone Marrow Transplantation|March 1, 1990
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicityS I Bearman, F B Petersen, R A Schor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Regimen-related toxicity in patients undergoing bone marrow transplantationS I Bearman, F R Appelbaum, C D Buckner, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Bone Marrow Transplantation|January 1, 1991
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemiaC D Buckner, R A Clift, F R Appelbaum, et al.
Experimental Hematology|January 1, 1987
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processorN R Jin, R Hill, G Segal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.
Cytotherapy|May 6, 2010
Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumorsA C Bills, W F Green, A Tsodikov, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|December 18, 2012
Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulinF Ostronoff, F Milano, T Gooley, et al.
Bone Marrow Transplantation|August 1, 1993
Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemiaM C Benyunes, C Massumoto, A York, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 11, 2015
The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantationC D Ford, B K Lopansri, M A Gazdik, et al.
Bone Marrow Transplantation|March 1, 1990
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicityS I Bearman, F B Petersen, R A Schor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Regimen-related toxicity in patients undergoing bone marrow transplantationS I Bearman, F R Appelbaum, C D Buckner, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Bone Marrow Transplantation|January 1, 1991
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemiaC D Buckner, R A Clift, F R Appelbaum, et al.
Experimental Hematology|January 1, 1987
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processorN R Jin, R Hill, G Segal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapyC H Weaver, F R Appelbaum, F B Petersen, et al.
Cytotherapy|May 6, 2010
Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumorsA C Bills, W F Green, A Tsodikov, et al.
Pageof 9